SALIVARY GLAND CANCER UK
Focused on rare salivary gland cancers such as Adenoid Cystic Carcinoma, we provide information and support to people affected by, treating, or researching these conditions. We organise regular networking meetings and provide the opportunity to input into ground-breaking research projects and donate to the biobank. We are working to develop and improve access to, the newest targeted therapies.
Objects
1. THE RELIEF OF SICKNESS AND THE PRESERVATION OF HEALTH AMONG PEOPLE AFFECTED BY SALIVARY GLAND CANCERS BY:I. ACTING AS AN ADVOCATE AND ASSISTING PATIENTS/CARERS OF THOSE DIAGNOSED WITH SALIVARY GLAND CANCER BY PROVIDING PEER SUPPORT AND INFORMATION ABOUT THEIR DISEASE, CARE AND TREATMENT.II. PROMOTING AND ASSISTING RESEARCH INTO ALL ASPECTS OF SALIVARY GLAND CANCERS, INCLUDING CAUSES, DIAGNOSIS, TREATMENT AND CURE.2. TO ADVANCE THE EDUCATION OF THE PUBLIC IN ALL AREAS RELATING TO SALIVARY GLAND CANCERS, INCLUDING RAISING AWARENESS OF THE SYMPTOMS OF SALIVARY GLAND CANCERS.
Financial health, per its FY2024 accounts
The accounts state that the charity held £68,381 in cash at the end of the period, resulting in an in-year deficit of £36,451. Despite this deficit, the trustees report that the financial position remains robust due to sufficient brought-forward funds from a prior year surplus. The trustees confirm there are no uncertainties regarding the charity's ability to continue as a going concern.
What the accounts disclose
“The charity received income of £37,336 (prior year £90,250) from donations raised through fund raising initiatives and personal legacies.”
“The cash balance is held in order to support the overall objectives of the charity. Cash is used to cover operating expenses, develop the charity’s presence through marketing and fund specific patient/clinician events. Cash held is also the source funds for the grants we have issued and for any other grant making opportunities that may arise.”
Policies the charity declares
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Risk management
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
Trustees
- Jacqueline Ann O'Connorchair
- Barry Thomas
- Dr ROBERT METCALF
- Emma Hallam
- Sally Yvonne Crowe
- Shane Draper
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £37k | £74k |
| 31/12/2023 | £90k | £34k |
| 31/12/2022 | £23k | £15k |
| 31/12/2021 | £28k | £15k |
| 31/12/2020 | £12k | £3k |
Common questions
Is SALIVARY GLAND CANCER UK financially healthy?
Per its FY2024 accounts: The accounts state that the charity held £68,381 in cash at the end of the period, resulting in an in-year deficit of £36,451. Despite this deficit, the trustees report that the financial position remains robust due to sufficient brought-forward funds from a prior year surplus. The trustees confirm there are no uncertainties regarding the charity's ability to continue as a going concern. Its FY2024 accounts were independently examined.